Pegylated adrenomedullin

N/A

Report date: 2023/04/19 20:00:28

Base Information

Drug NamePegylated adrenomedullin
Drug Alias NameBAY1097761PEGylated adrenomedullinPeg adrenomedullinBAY-1097761
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAdrenomedullin receptor agonists
TargetsAdrenomedullin receptor
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaItalyAustria +[7] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, Adult

Other Information

ATC CodeN/A
Related LinksN/A